Senate Health Committee pricing hearing
Drug safety and pricing hearing scheduled for May 23 has been postponed due to scheduling conflicts (1"The Pink Sheet" May 15, p. 8)
You may also be interested in...
The "Maine Rx" discount law seeks Federal Supply Schedule-level rebates for prescriptions filled in Maine by October 2001.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials